Stay updated on Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    - The page revision label was updated to v3.6.3, replacing the previous v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-04T04:17:42.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.0 to v3.6.2, indicating a software update to the page’s backend or UI rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T01:50:50.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now states that recruitment has ceased for participants and adds new guidance sections, while reorganizing the Intervention/Treatment content. It also includes a version update to Revision: v3.6.0, replacing the older v3.5.5 tag.
    Difference
    0.4%
    Check dated 2026-06-12T16:09:03.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.5 is now shown, indicating a site update; study details and navigation remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-05T09:15:45.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    New page revision v3.5.4 was published, replacing the prior v3.5.3. This marks a minor update to the page version, with no apparent changes to the study content.
    Difference
    0.1%
    Check dated 2026-05-15T07:40:35.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page’s displayed release/revision version from v3.5.2 to v3.5.3 without changing the study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:21:52.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.